Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Non-Current Deffered Revenue (2019 - 2023)

Historic Non-Current Deffered Revenue for CureVac (CVAC) over the last 5 years, with Q4 2023 value amounting to $51.8 million.

  • CureVac's Non-Current Deffered Revenue fell 3008.08% to $51.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $51.8 million, marking a year-over-year decrease of 3008.08%. This contributed to the annual value of $51.8 million for FY2023, which is 3008.08% down from last year.
  • Latest data reveals that CureVac reported Non-Current Deffered Revenue of $51.8 million as of Q4 2023, which was down 3008.08% from $74.0 million recorded in Q4 2022.
  • CureVac's 5-year Non-Current Deffered Revenue high stood at $596.2 million for Q4 2020, and its period low was $51.8 million during Q4 2023.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $74.0 million (2022), whereas its average is $178.8 million.
  • As far as peak fluctuations go, CureVac's Non-Current Deffered Revenue skyrocketed by 71563.19% in 2020, and later crashed by 8343.29% in 2021.
  • Quarter analysis of 5 years shows CureVac's Non-Current Deffered Revenue stood at $73.1 million in 2019, then soared by 715.63% to $596.2 million in 2020, then tumbled by 83.43% to $98.8 million in 2021, then fell by 25.07% to $74.0 million in 2022, then plummeted by 30.08% to $51.8 million in 2023.
  • Its last three reported values are $51.8 million in Q4 2023, $74.0 million for Q4 2022, and $98.8 million during Q4 2021.